A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran

We compared the efficacy and safety of a biosimilar form of beta-interferon-1a (Actovex) versus the reference product in the treatment of relapsing remitting multiple sclerosis (RRMS). In a double blind, randomized phase 3 clinical trial, we evaluated 138 patients with RRMS that were allocated to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabavi, Seyed Massood, Abolfazli, Roya, Etemadrezaei, Ali, Hosseini, Hamed, Moradi, Nahid, Shahriari, Sanaz, Mehdipour, Baharak, Shekarchi, Babak, Soltanzadeh, Akbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934945/
https://www.ncbi.nlm.nih.gov/pubmed/32641970
http://dx.doi.org/10.22037/ijpr.2019.14503.12441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934945/
https://www.ncbi.nlm.nih.gov/pubmed/32641970
http://dx.doi.org/10.22037/ijpr.2019.14503.12441

Ejemplares similares